Steiger Kyle, Farooqui Naba, Killian Jill M, Redfield Margaret, Dunlay Shannon M
Department of Internal Medicine, Mayo Clinic, Rochester, MN. Electronic address: https://twitter.com/KyleGSteiger.
Department of Internal Medicine, Mayo Clinic, Rochester, MN. Electronic address: https://twitter.com/clockwork_naba.
Mayo Clin Proc. 2025 Jul 28. doi: 10.1016/j.mayocp.2024.12.014.
To describe the clinical correlates of right ventricular function in advanced/stage D heart failure and its association with risks of death and hospitalizations in this population.
This retrospective cohort study included adult residents of Olmsted County, Minnesota, with advanced heart failure between 2007 and 2018. Patients were classified by right ventricular function assessed by echocardiography at the time of advanced heart failure. The association of right ventricular function with risks of death and hospitalizations through June 30, 2023, was examined by Cox and Andersen-Gill models, respectively.
There were 925 patients included in the analysis (mean age, 77.2 years; 44.5% women). Right ventricular function was normal in 29% (n=266), mildly reduced in 38% (n=349), and moderately to severely reduced in 33% (n=310). Percentage with preserved left ventricular ejection fraction was 60.2%, 41.3%, and 31.0% in patients with normal right ventricular function, mild right ventricular dysfunction, and moderate to severe right ventricular dysfunction, respectively (P<.001). Compared with patients with normal right ventricular function, moderate to severe right ventricular dysfunction was associated with increased risks of mortality: all-cause (adjusted hazard ratio, 1.30; 95% CI, 1.09 to 1.55) and cardiovascular (adjusted hazard ratio, 1.32; 95% CI, 1.06 to 1.66). There was no significant difference in all-cause or heart failure-specific hospitalization risk by right ventricular function.
Right ventricular dysfunction was present in 71% patients with advanced heart failure and increased with decreasing left ventricular ejection fraction. Moderate to severe right ventricular dysfunction was associated with increased all-cause and cardiovascular death but had no association with hospitalizations.
描述晚期/D期心力衰竭患者右心室功能的临床相关因素及其与该人群死亡和住院风险的关联。
这项回顾性队列研究纳入了2007年至2018年间明尼苏达州奥尔姆斯特德县患有晚期心力衰竭的成年居民。在晚期心力衰竭时,通过超声心动图评估右心室功能对患者进行分类。分别采用Cox模型和Andersen-Gill模型检验右心室功能与截至2023年6月30日的死亡和住院风险的关联。
925例患者纳入分析(平均年龄77.2岁;44.5%为女性)。29%(n = 266)的患者右心室功能正常,38%(n = 349)的患者右心室功能轻度降低,33%(n = 310)的患者右心室功能中度至重度降低。右心室功能正常、轻度右心室功能障碍和中度至重度右心室功能障碍患者的左心室射血分数保留比例分别为60.2%、41.3%和31.0%(P <.001)。与右心室功能正常的患者相比,中度至重度右心室功能障碍与死亡风险增加相关:全因死亡(调整后风险比,1.30;95%置信区间,1.09至1.55)和心血管死亡(调整后风险比,1.32;9%置信区间,1.06至1.66)。右心室功能在全因或心力衰竭特异性住院风险方面无显著差异。
71%的晚期心力衰竭患者存在右心室功能障碍,且随着左心室射血分数降低而增加。中度至重度右心室功能障碍与全因和心血管死亡风险增加相关,但与住院无关。